ASCO 2022 Conference Coverage


 

ASCO 2022 on Survival Update of Neoadjuvant Ipi + Nivo in Macroscopic Stage III Melanoma: The OpACIN and OpACIN-neo Trials

40 views
June 16, 2022
Comments 0
Login to view comments. Click here to Login